9Bio

9Bio Therapeutics leverages its AI-guided structural biology platform to design tumour-specific, conditionally active cancer therapeutics. The platform stands out by modelling cancer-associated proteins under the unique biochemical conditions of the tumour microenvironment, which allows 9Bio to develop therapeutics wit

9Bio is a company in cancer.

Profile

9Bio Therapeutics leverages its AI-guided structural biology platform to design tumour-specific, conditionally active cancer therapeutics. The platform stands out by modelling cancer-associated proteins under the unique biochemical conditions of the tumour microenvironment, which allows 9Bio to develop therapeutics with enhanced cancer specificity. Initially, 9Bio is focusing on high-impact targets such as anti-PD-L1, developed as an […]

The company sits in the cancer segment, where it competes on its core product or service.

Its current recorded stage is Creative Destruction Lab alumni company.

Website: www.9bio.ca